167 related articles for article (PubMed ID: 29097360)
1. Allergic eye disease.
Patel DS; Arunakirinathan M; Stuart A; Angunawela R
BMJ; 2017 Nov; 359():j4706. PubMed ID: 29097360
[No Abstract] [Full Text] [Related]
2. [Ocular allergies].
Messmer EM
Ophthalmologe; 2005 May; 102(5):527-43; quiz 544. PubMed ID: 15806370
[TBL] [Abstract][Full Text] [Related]
3. The role of aspirin in vernal keratoconjunctivitis.
Anwar MS
J Coll Physicians Surg Pak; 2003 Mar; 13(3):178-9. PubMed ID: 12689545
[No Abstract] [Full Text] [Related]
4. Vernal kerato-conjunctivitis: an allergic disease of the eyes of children.
Rice NS; Jones BR
Clin Allergy; 1973 Dec; 3 Suppl():629-37. PubMed ID: 4220246
[No Abstract] [Full Text] [Related]
5. Pharmacotherapeutic management of atopic keratoconjunctivitis.
Hossain IT; Sanghi P; Manzouri B
Expert Opin Pharmacother; 2020 Oct; 21(14):1761-1769. PubMed ID: 32602382
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of allergic conjunctivitis in children: the out-patients' department experience (allergic conjunctivitis in children: management and care).
Napoli G; Allegri P; Musso C; Morchio AA; Callegarini L; Murialdo U; Tanca D; Marrè V
Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):21-4. PubMed ID: 15745373
[No Abstract] [Full Text] [Related]
7. Hyposensitization in the treatment of resistant cases of vernal keratoconjunctivitis.
Mahdy RA; Nada WM; Shahien EA; Boghdadi GA; Marei AA
Cutan Ocul Toxicol; 2010 Sep; 29(3):198-202. PubMed ID: 20670088
[TBL] [Abstract][Full Text] [Related]
8. Immunopathological Features of Severe Chronic Atopic Keratoconjunctivitis and Effects of Topical Cyclosporine Treatment.
Utine CA; Stern M; Akpek EK
Ocul Immunol Inflamm; 2019; 27(7):1184-1193. PubMed ID: 30189151
[TBL] [Abstract][Full Text] [Related]
9. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
[TBL] [Abstract][Full Text] [Related]
10. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
[TBL] [Abstract][Full Text] [Related]
11. Atopic Keratoconjunctivitis: Pharmacotherapy for the Elderly.
Ridolo E; Kihlgren P; Pellicelli I; Nizi MC; Pucciarini F; Incorvaia C
Drugs Aging; 2019 Jul; 36(7):581-588. PubMed ID: 31055787
[TBL] [Abstract][Full Text] [Related]
12. Ocular allergy. Scratching the surface of the red eye.
Friedlaender MH
Postgrad Med; 1986 Apr; 79(5):261-71. PubMed ID: 3083407
[TBL] [Abstract][Full Text] [Related]
13. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops.
Ozcan AA; Ersoz TR; Dulger E
Cornea; 2007 Oct; 26(9):1035-8. PubMed ID: 17893529
[TBL] [Abstract][Full Text] [Related]
14. [Application of corticosteroid eye drops for allergic eye diseases in children].
Csorba A; Soproni A; Maneschg O; Nagy ZZ; Szamosi A
Orv Hetil; 2019 Mar; 160(9):329-337. PubMed ID: 30798620
[TBL] [Abstract][Full Text] [Related]
15. The clinical spectrum of ocular allergy.
Brémond-Gignac D
Curr Allergy Asthma Rep; 2002 Jul; 2(4):321-4. PubMed ID: 12044268
[TBL] [Abstract][Full Text] [Related]
16. [Uncontrolled use of corticosteroid eye drops causing glaucoma and vision impairement for a young man].
Liinamaa J; Falck A; Airaksinen PJ
Duodecim; 2006; 122(3):333-6. PubMed ID: 16619891
[No Abstract] [Full Text] [Related]
17. Safety and efficacy of lodoxamide in vernal keratoconjunctivitis.
Das D; Khan M; Gul A; Alam R
J Pak Med Assoc; 2011 Mar; 61(3):239-41. PubMed ID: 21465936
[TBL] [Abstract][Full Text] [Related]
18. [GUIDELINES FOR THE CLINICAL MANAGEMENT OF ALLERGIC CONJUNCTIVAL DISEASE THE POINT OF THE MANAGEMENT WITH USING CONVENTIONAL TOOL AND EYE DROPS].
Takamura E
Arerugi; 2018; 67(2):103-107. PubMed ID: 29553108
[No Abstract] [Full Text] [Related]
19. Topical cyclosporine 0.5 per cent and preservative-free ketorolac tromethamine 0.5 per cent in vernal keratoconjunctivitis.
Kosrirukvongs P; Luengchaichawange C
J Med Assoc Thai; 2004 Feb; 87(2):190-7. PubMed ID: 15061303
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
